Skip to main content
Premium Trial:

Request an Annual Quote

John Linnan, May Van, Bruce Holm, James Glover

Premium

John Linnan has been appointed vice president of sales at Beverly, Mass.-based Agencourt Bioscience. Linnan comes to Agencourt from Applied Biosystems, where he most recently worked as district sales manager for New England. Prior to holding this position, Linnan was the regional sales manager for New England, mid-Atlantic, and Eastern Canada for Perspective Biosystems of Hertford, UK. He has also worked at Abbott Diagnostics in various sales positions. He holds a BA in marketing and management from James Madison University.

Agilent Technologies has named May Van as vice president and general manager of the consumables and services business in its Life Sciences and Chemical Analysis group, which includes Agilent’s proteomics business. Van, who joined Hewlett-Packard in 1997, and remained with Agilent when it spun out from its parent in 1999, is being promoted from a position as controller of the consumables and services business. Prior to joining the company, Van was the director of finance and administration at Integrated Circuit Systems. She has earned a bachelor’s degree of business administration in accounting from Texas Tech University, and an MBA from West Chester University in Pennsylvania.

Bruce Holm has been appointed director of the Buffalo Center of Excellence in Bioinformatics and Life Sciences of the University at Buffalo, which recently added a proteomics program. Holm was previously senior vice provost at the university, which is a branch of the State University of New York.

James Glover has been named chief financial officer of Beckman Coulter. Glover has held the post of interim CFO at Beckman Coulter since August 2003. He is a 21-year veteran of the company, having joined in 1983, and has most recently served as vice president, controller, and chief accounting officer, since early 2003. Glover, a certified public accountant, holds a BS in accounting from California State Polytechnic University, Pomona, as well as an MBA from Pepperdine University.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.